Skip to content
Wednesday, March 29, 2023
Latest:
  • SQI Diagnostics Submits RALI-Dx(TM) IL-6 Severity Triage Test for COVID-19 Patients to FDA for Emergency Use Authorization
  • Fusion Pharmaceuticals Appoints Donald Bergstrom, M.D., Ph.D., to Board of Directors
  • Eisai: Application Submitted for Additional Indication of Anti Cancer Agent Lenvima in Combination With Keytruda as a Treatment for Advanced Renal Cell Carcinoma in Japan
  • PsyBio Therapeutics Initiates Process Development of Proprietary Biosynthetic Norbaeocystin
  • MindMed Announces Inclusion in FTSE Russell Indexes
Biotech Stock Market News

Biotech Stock Market News

Know First, Act First

  • Cannabis & Cancer
  • General
  • Coronavirus
  • Financing & Fiscal
  • Shareholders
Fusion Pharmaceuticals Appoints Donald Bergstrom, M.D., Ph.D., to Board of Directors
BIOTCHNO Featured 

Fusion Pharmaceuticals Appoints Donald Bergstrom, M.D., Ph.D., to Board of Directors

April 1, 2021August 4, 2021 RJ
BirchBioMed Inc. Announces Positive Topline Data from Phase 2 Study of FS2 for Treatment of Keloid Scars
BIOTCHNO Featured 

BirchBioMed Inc. Announces Positive Topline Data from Phase 2 Study of FS2 for Treatment of Keloid Scars

January 22, 2021April 8, 2021 vanessa
PsyBio Therapeutics Initiates Process Development of Proprietary Biosynthetic Norbaeocystin
BIOTCHNO Trending 

PsyBio Therapeutics Initiates Process Development of Proprietary Biosynthetic Norbaeocystin

March 23, 2021April 20, 2021 Raza
MindMed’s LSD Neutralizer Study Begins
BIOTCHNO Trending 

MindMed’s LSD Neutralizer Study Begins

February 17, 2021April 8, 2021 Bachittar
Health Canada Approves BAVENCIO® for the Maintenance Treatment of Patients with Advanced Bladder Cancer
BIOTCHNO Trending 

Health Canada Approves BAVENCIO® for the Maintenance Treatment of Patients with Advanced Bladder Cancer

January 11, 2021April 20, 2021 vanessa
Mediwelcome: Bringing High-Quality Medical Service Genes, or an Internet Hospital Upstart?
BIOTCHNO Trending 

Mediwelcome: Bringing High-Quality Medical Service Genes, or an Internet Hospital Upstart?

January 6, 2021April 8, 2021 vanessa

General

SQI Diagnostics Submits RALI-Dx(TM) IL-6 Severity Triage Test for COVID-19 Patients to FDA for Emergency Use Authorization
BIOTCHNO General 

SQI Diagnostics Submits RALI-Dx(TM) IL-6 Severity Triage Test for COVID-19 Patients to FDA for Emergency Use Authorization

May 24, 2021June 7, 2021 Raza

Canada NewsWire Test Designed to Assist in Identifying Severe Inflammatory Response in Patients with Confirmed COVID-19 Illness TORONTO , April

MindMed Announces Inclusion in FTSE Russell Indexes
BIOTCHNO General 

MindMed Announces Inclusion in FTSE Russell Indexes

March 22, 2021July 26, 2021 Raza
BioVaxys and BioElpida Sign Term Sheet for Clinical Grade BVX-0918A Bio-production
BIOTCHNO General 

BioVaxys and BioElpida Sign Term Sheet for Clinical Grade BVX-0918A Bio-production

February 18, 2021April 30, 2021 Desiree Justice
Beyond Medical Announces Appointment of Michael Kelly to its Board of Director and is Working to Close the Final Tranche of Non Brokered Private Placement
BIOTCHNO General 

Beyond Medical Announces Appointment of Michael Kelly to its Board of Director and is Working to Close the Final Tranche of Non Brokered Private Placement

February 11, 2021April 30, 2021 Bachittar
Acknowledged scientific leader and Novartis veteran joins Sai Life Sciences
BIOTCHNO General 

Acknowledged scientific leader and Novartis veteran joins Sai Life Sciences

February 11, 2021April 8, 2021 Bachittar

Coronavirus

Seegene develops world first COVID-19 variant test capable of identifying origins of virus variants
BIOTCHNO Coronavirus 

Seegene develops world first COVID-19 variant test capable of identifying origins of virus variants

January 31, 2021April 30, 2021 vanessa

Canada NewsWire SEEGENE ROLLS OUT FIRST COVID-19 MUTANT IDENTIFICATION TEST COVID-19 TEST MANUFACTURER CONTINUES TRACKING VARIANTS S. KOREAN FIRM COMMITTED

SQI Diagnostics Announces Patient Enrollment Begins for Its COVID-19 HOME Antibody Test Clinical Study
BIOTCHNO Coronavirus 

SQI Diagnostics Announces Patient Enrollment Begins for Its COVID-19 HOME Antibody Test Clinical Study

January 25, 2021April 30, 2021 vanessa
Providence Therapeutics COVID-19 Vaccine Receives Health Canada Authorization to Begin Clinical Trials
BIOTCHNO Coronavirus 

Providence Therapeutics COVID-19 Vaccine Receives Health Canada Authorization to Begin Clinical Trials

December 23, 2020April 30, 2021 vanessa
Azooka Labs unveils Safe MTM to Store COVID-19 Samples at Room Temperature for up to a week
BIOTCHNO Coronavirus 

Azooka Labs unveils Safe MTM to Store COVID-19 Samples at Room Temperature for up to a week

December 15, 2020April 30, 2021 vanessa

Financing & Fiscal

Willow Biosciences Provides Update on Acceleration of Expiry Date of Outstanding Warrants Issued Pursuant to October 2020 Unit Financing
BIOTCHNO Financing & Fiscal 

Willow Biosciences Provides Update on Acceleration of Expiry Date of Outstanding Warrants Issued Pursuant to October 2020 Unit Financing

March 3, 2021June 2, 2021 Raza

Canada NewsWire VANCOUVER, BC , March 3, 2021 /CNW/ – Willow Biosciences Inc. (” Willow ” or the ” Company “) (TSX: WLLW)

MindMed Reaches Agreement to Acquire HealthMode, a Leading Machine Learning Digital Medicine Company
BIOTCHNO Financing & Fiscal 

MindMed Reaches Agreement to Acquire HealthMode, a Leading Machine Learning Digital Medicine Company

February 19, 2021April 30, 2021 Bachittar
SQI Diagnostics Announces New Corporate Website
BIOTCHNO Financing & Fiscal 

SQI Diagnostics Announces New Corporate Website

February 18, 2021April 30, 2021 Bachittar
Menarini Silicon Biosystems announces launch of CellMag(TM) product line offering affordable Gold Standard Circulating Tumor Cells capture
BIOTCHNO Financing & Fiscal 

Menarini Silicon Biosystems announces launch of CellMag(TM) product line offering affordable Gold Standard Circulating Tumor Cells capture

February 16, 2021April 30, 2021 Bachittar

Shareholders

ESSA Pharma to Present at Upcoming March Investor Conferences
BIOTCHNO Shareholders 

ESSA Pharma to Present at Upcoming March Investor Conferences

February 25, 2021May 17, 2021 Raza

Canada NewsWire HOUSTON, Texas and VANCOUVER, Canada, Feb. 25, 2021 /CNW/ – ESSA Pharma Inc. (“ESSA”, or the “Company”) (NASDAQ: EPIX), a

Arbitrator Rules for Neptune Wellness Solutions Inc. in Dispute With Azpa Pharmaceuticals Pty. Ltd.
BIOTCHNO Shareholders 

Arbitrator Rules for Neptune Wellness Solutions Inc. in Dispute With Azpa Pharmaceuticals Pty. Ltd.

February 18, 2021April 30, 2021 Bachittar
ESSA Pharma Announces Proposed Public Offering of Common Shares
BIOTCHNO Shareholders 

ESSA Pharma Announces Proposed Public Offering of Common Shares

February 16, 2021April 30, 2021 Bachittar
Mountain Valley MD Holdings to Commence Trading on OTCQB Market Under Ticker MVMDF
BIOTCHNO Shareholders 

Mountain Valley MD Holdings to Commence Trading on OTCQB Market Under Ticker MVMDF

February 12, 2021April 30, 2021 Bachittar
QYNAPSE Joins Decentralized Trials & Research Alliance (DTRA) To Democratize And Accelerate Clinical Trials
BIOTCHNO Shareholders 

QYNAPSE Joins Decentralized Trials & Research Alliance (DTRA) To Democratize And Accelerate Clinical Trials

December 30, 2020April 30, 2021 Desiree Justice

Cannabis

Eisai: Application Submitted for Additional Indication of Anti Cancer Agent Lenvima in Combination With Keytruda as a Treatment for Advanced Renal Cell Carcinoma in Japan
BIOTCHNO Cannabis & Cancer 

Eisai: Application Submitted for Additional Indication of Anti Cancer Agent Lenvima in Combination With Keytruda as a Treatment for Advanced Renal Cell Carcinoma in Japan

March 31, 2021July 19, 2021 Raza

TOKYO, Mar 31, 2021 – (JCN Newswire) – Eisai Co., Ltd. and MSD K.K. a subsidiary of Merck & Co.,

The Valens Company Expands Cannabis 2.0 & 3.0
BIOTCHNO Cannabis & Cancer 

The Valens Company Expands Cannabis 2.0 & 3.0

February 25, 2021April 20, 2021 Bachittar
PAOG Announces CBD Nutraceuticals Expansion Plan Multimedia Presentation
BIOTCHNO Cannabis & Cancer 

PAOG Announces CBD Nutraceuticals Expansion Plan Multimedia Presentation

February 16, 2021April 30, 2021 Bachittar
ESSA Pharma Presents Favorable Initial Phase 1 Clinical Pharmacology Data of EPI-7386 for Advanced Forms of Prostate Cancer at the 2021 ASCO Genitourinary Cancers Symposium
BIOTCHNO Cannabis & Cancer 

ESSA Pharma Presents Favorable Initial Phase 1 Clinical Pharmacology Data of EPI-7386 for Advanced Forms of Prostate Cancer at the 2021 ASCO Genitourinary Cancers Symposium

February 11, 2021April 30, 2021 Bachittar
  • Disclaimer
  • Privacy Policy
TD Media LLC dba Life Water Media
5826 New Territory Blvd. Unit #2144 Sugar Land, TX 77479